Cargando…

Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates

INTRODUCTION: Age‐related neuropathology associated with sporadic Alzheimer's disease (AD) often develops well before the onset of symptoms. Given AD's long preclinical period, translational models are needed to identify early signatures of pathological decline. METHODS: Using structural m...

Descripción completa

Detalles Bibliográficos
Autores principales: Frye, Brett M., Craft, Suzanne, Register, Thomas C., Kim, Jeongchul, Whitlow, Christopher T., Barcus, Richard A., Lockhart, Samuel N., Sai, Kiran Kumar Solingapuram, Shively, Carol A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918111/
https://www.ncbi.nlm.nih.gov/pubmed/35310523
http://dx.doi.org/10.1002/trc2.12284
_version_ 1784668664452087808
author Frye, Brett M.
Craft, Suzanne
Register, Thomas C.
Kim, Jeongchul
Whitlow, Christopher T.
Barcus, Richard A.
Lockhart, Samuel N.
Sai, Kiran Kumar Solingapuram
Shively, Carol A.
author_facet Frye, Brett M.
Craft, Suzanne
Register, Thomas C.
Kim, Jeongchul
Whitlow, Christopher T.
Barcus, Richard A.
Lockhart, Samuel N.
Sai, Kiran Kumar Solingapuram
Shively, Carol A.
author_sort Frye, Brett M.
collection PubMed
description INTRODUCTION: Age‐related neuropathology associated with sporadic Alzheimer's disease (AD) often develops well before the onset of symptoms. Given AD's long preclinical period, translational models are needed to identify early signatures of pathological decline. METHODS: Using structural magnetic resonance imaging and cognitive assessments, we examined the relationships among age, cognitive performance, and neuroanatomy in 48 vervet monkeys (Chlorocebus aethiops sabaeus) ranging from young adults to very old. RESULTS: We found negative associations of age with cortical gray matter volume (P = .003) and the temporal‐parietal cortical thickness meta‐region of interest (P = .001). Additionally, cortical gray matter volumes predicted working memory at approximately 1‐year follow‐up (correct trials at the 20s delay [P = .008]; correct responses after longer delays [P = .004]). DISCUSSION: Cortical gray matter diminishes with age in vervets in regions relevant to AD, which may increase risk of cognitive impairment. This study lays the groundwork for future investigations to test therapeutics to delay or slow pathological decline.
format Online
Article
Text
id pubmed-8918111
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89181112022-03-18 Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates Frye, Brett M. Craft, Suzanne Register, Thomas C. Kim, Jeongchul Whitlow, Christopher T. Barcus, Richard A. Lockhart, Samuel N. Sai, Kiran Kumar Solingapuram Shively, Carol A. Alzheimers Dement (N Y) Research Articles INTRODUCTION: Age‐related neuropathology associated with sporadic Alzheimer's disease (AD) often develops well before the onset of symptoms. Given AD's long preclinical period, translational models are needed to identify early signatures of pathological decline. METHODS: Using structural magnetic resonance imaging and cognitive assessments, we examined the relationships among age, cognitive performance, and neuroanatomy in 48 vervet monkeys (Chlorocebus aethiops sabaeus) ranging from young adults to very old. RESULTS: We found negative associations of age with cortical gray matter volume (P = .003) and the temporal‐parietal cortical thickness meta‐region of interest (P = .001). Additionally, cortical gray matter volumes predicted working memory at approximately 1‐year follow‐up (correct trials at the 20s delay [P = .008]; correct responses after longer delays [P = .004]). DISCUSSION: Cortical gray matter diminishes with age in vervets in regions relevant to AD, which may increase risk of cognitive impairment. This study lays the groundwork for future investigations to test therapeutics to delay or slow pathological decline. John Wiley and Sons Inc. 2022-03-13 /pmc/articles/PMC8918111/ /pubmed/35310523 http://dx.doi.org/10.1002/trc2.12284 Text en © 2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Frye, Brett M.
Craft, Suzanne
Register, Thomas C.
Kim, Jeongchul
Whitlow, Christopher T.
Barcus, Richard A.
Lockhart, Samuel N.
Sai, Kiran Kumar Solingapuram
Shively, Carol A.
Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
title Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
title_full Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
title_fullStr Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
title_full_unstemmed Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
title_short Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
title_sort early alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918111/
https://www.ncbi.nlm.nih.gov/pubmed/35310523
http://dx.doi.org/10.1002/trc2.12284
work_keys_str_mv AT fryebrettm earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT craftsuzanne earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT registerthomasc earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT kimjeongchul earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT whitlowchristophert earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT barcusricharda earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT lockhartsamueln earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT saikirankumarsolingapuram earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates
AT shivelycarola earlyalzheimersdiseaselikereductionsingraymatterandcognitivefunctionwithaginginnonhumanprimates